Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Joachim

Showing results (11-20 of 353) with videos related to

Pageof 36
Sort By:
Blood|January 20, 2007
How I treat refractory acute GVHDH Joachim Deeg
Blood Advances|October 4, 2021
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantationH Joachim Deeg
Frontiers in Immunology|May 10, 2021
Chimerism, the Microenvironment and Control of LeukemiaH Joachim Deeg
Leukemia Research|May 15, 2002
Marrow stroma in MDS: culprit or bystander?H Joachim Deeg
Blood|August 27, 2011
GVHD-free with Campath?H Joachim Deeg
Minerva Anestesiologica|May 5, 2009
Influence of beta-blockers on the outcome of at risk patientsH-Joachim Priebe
Croatian Medical Journal|September 1, 2022
Inter-University Centre in Dubrovnik: 50 years of fostering science without bordersH Joachim Seitz
Blood|June 22, 2023
Reward from half a matchH Joachim Deeg
Pediatric Transplantation|August 17, 2006
Should skin grafts be used to test for tolerance?H Joachim Deeg
Cancer|October 12, 2018
More than one angle to target aplastic anemia?H Joachim Deeg
Pageof 36

Showing results (11-20 of 353) with videos related to

Sort By:
Pageof 36
Blood|January 20, 2007
How I treat refractory acute GVHDH Joachim Deeg
Blood Advances|October 4, 2021
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantationH Joachim Deeg
Frontiers in Immunology|May 10, 2021
Chimerism, the Microenvironment and Control of LeukemiaH Joachim Deeg
Leukemia Research|May 15, 2002
Marrow stroma in MDS: culprit or bystander?H Joachim Deeg
Blood|August 27, 2011
GVHD-free with Campath?H Joachim Deeg
Minerva Anestesiologica|May 5, 2009
Influence of beta-blockers on the outcome of at risk patientsH-Joachim Priebe
Croatian Medical Journal|September 1, 2022
Inter-University Centre in Dubrovnik: 50 years of fostering science without bordersH Joachim Seitz
Blood|June 22, 2023
Reward from half a matchH Joachim Deeg
Pediatric Transplantation|August 17, 2006
Should skin grafts be used to test for tolerance?H Joachim Deeg
Cancer|October 12, 2018
More than one angle to target aplastic anemia?H Joachim Deeg
Pageof 36